A Pill to Fight Obesity Is on the Verge of Approval
The next big obesity medication coming down the pipeline will likely come in pill form. Eli Lilly has just released the latest positive Phase III trial results of its experimental…
Digital Lifestyle Serve - Money Making Blog
The next big obesity medication coming down the pipeline will likely come in pill form. Eli Lilly has just released the latest positive Phase III trial results of its experimental…
Thinking about taking Ozempic but worried about losing too much muscle? New clinical trial data might point to a future where that’s no longer a concern. Regeneron Pharmaceuticals announced the…
Scientists in California tested a way to coax certain fat cells to burn calories, rather than simply store energy. In new research involving mice, the team found it was possible…
Children and teens with high body mass index should be guided toward intensive lifestyle interventions to manage their weight, an influential panel of experts is recommending. Suggested Reading Automation Never…
It’s hard to go a day without hearing something new about the latest diabetes and obesity medications, semaglutide and tirzepatide. Usually, the buzz is positive, but there has been a…
Semaglutide, the active ingredient in popular diabetes and obesity drugs Ozempic and Wegovy, can also tweak people’s taste buds for the better, preliminary research suggests. Scientists found that women taking…
The future of weight loss is looking more varied by the second. This week, scientists have reported the preliminary findings of a small trial testing out a novel, non-surgical procedure…
Senator Bernie Sanders (I-VT) is taking aim at one of Big Pharma’s newest cash cows: the latest generation of effective obesity medications. On Wednesday, Sanders’ office announced that the senator…
The newest weight loss drug on the market, Zepbound, might also help keep people’s snoring down. On Wednesday, Eli Lilly announced the preliminary results of two Phase III trials testing…
The results of a nine-month investigation by health regulators in the European Union should be comforting for anyone taking Ozempic and other similar drugs to treat type 2 diabetes and/or…